Stay updated on Selinexor Plus DRd in New Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Selinexor Plus DRd in New Multiple Myeloma Clinical Trial page.

Latest updates to the Selinexor Plus DRd in New Multiple Myeloma Clinical Trial page
- Check3 days agoChange DetectedThe site revision changes from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check10 days agoChange DetectedAn NIH notice says agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence.” It appears as a site-wide announcement rather than an update to the study record.SummaryDifference0.7%

- Check17 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov release as v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check24 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check45 days agoChange DetectedA new revision entry v3.7.0 was added to the study record history, and the older revision v3.6.6 was removed. This reflects an update to the page’s version history rather than changes to the study details.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page revision label was updated from v3.6.5 to v3.6.6, indicating a minor metadata update to the page.SummaryDifference0.1%

Stay in the know with updates to Selinexor Plus DRd in New Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selinexor Plus DRd in New Multiple Myeloma Clinical Trial page.